Langenfeld, Germany

Gunter Cordes

This inventor holds 1 USPTO granted patent. Top assignee: Rotta Research B.v.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gunter Cordes. Retrieved from https://idiyas.com/inventor/gunter-cordes-ft6365u5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gunter Cordes: Innovator in Transdermal Drug Delivery

Introduction

Gunter Cordes is a notable inventor based in Lagenfeld, Germany. He has made significant contributions to the field of transdermal drug delivery systems. His innovative work has led to the development of a unique patent that addresses important medical needs.

Latest Patents

Gunter Cordes holds a patent for a transdermal estradiol/progestogen agent patch and its production. This invention is designed to provide a more effective method for hormone delivery, improving patient compliance and therapeutic outcomes. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Cordes is currently employed at Rotta Research B.V., a company known for its focus on pharmaceutical research and development. His role at the company allows him to further explore innovative solutions in drug delivery systems. His work has been instrumental in advancing the field and enhancing patient care.

Collaborations

Throughout his career, Gunter Cordes has collaborated with talented professionals, including Antonino Santoro and Ivo Setnikar. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Gunter Cordes is a distinguished inventor whose work in transdermal drug delivery has made a significant impact in the medical field. His contributions continue to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…